10 things you need to know before the April 22 opening bell

Market

Updated: April 22, 2021 7:46 AM IST

The Indian market is likely to open on a cautious note on Thursday over concerns about the country’s second wave of COVID-19 and tightening restrictions in various states. Meanwhile, SGX Nifty traded around 14,156, compared to Tuesday’s close of 14,296 Nifty Futures.

    1. Wall Street: The shares ended largely on Wall Street, after winning steadily throughout the day.  The S&P 500 index rose 0.9 percent on Wednesday after its first loss back in March.  The Dow Jones industrial average rose 0.9 percent and the Nasdaq rose 1.2 percent.

1. Wall Street: Shares ended much higher on Wall Street, after winning steadily throughout the day. The S&P 500 index rose 0.9 percent on Wednesday after its first loss back in March. The Dow Jones industrial average rose 0.9 percent and the Nasdaq rose 1.2 percent.

    2. Asian stocks: Asian-Pacific stocks rose on Thursday after a return overnight on Wall Street.  Japan's Nikkei 225 rose 1.2% in early trading, partially recovering from two days of losses earlier in the week.  Shares in Australia rose more as the S & P / ASX 200 rose 0.21 percent.  The largest MSCI index of Asia-Pacific equities outside Japan traded 0.07 percent higher.

2. Asian stocks: Shares in Asia-Pacific rose on Thursday after a return to Wall Street overnight. Japan’s Nikkei 225 rose 1.2% in early trading, partially recovering from two days of losses earlier in the week. Shares in Australia rose more as the S & P / ASX 200 rose 0.21 percent. The largest MSCI index of Asia-Pacific equities outside Japan traded 0.07 percent higher.

    3. Dalal Street: India's capital markets, currencies, debt and commodities were closed on Wednesday at the expense of Ram Navami.

3. Dalal Street: India’s capital markets, currencies, debt and commodities were closed on Wednesday at the expense of Ram Navami.

    4. Oil: Oil prices have been weighed by concerns that rising cases of COVID-19 in India will reduce fuel demand in the world's third largest oil importer.  U.S. crude oil fell 1.1 percent to $ 61.99 a barrel recently, and Brent was $ 65.97, down 0.9 percent that day.

4. Oil: Oil prices have been weighed by concerns that rising cases of COVID-19 in India will reduce fuel demand in the world’s third-largest oil importer. U.S. crude oil fell 1.1 percent to $ 61.99 a barrel recently, and Brent was $ 65.97, down 0.9 percent that day.

    5. Rupee: The rupee reduced its initial gains on Tuesday to close marginally 1 paisa at 74.88 against the US dollar on Tuesday due to concerns that the alarming rise in COVID-19 cases could derail the country's economic recovery.

5. Rupee: The rupee reduced its initial gains on Tuesday to close 1 paisa on Tuesday at 74.88 against the US dollar on Tuesday, due to concerns that the alarming rise in COVID-19 cases could derail the country’s economic recovery.

    6. Gold: Gold rose 1 percent on Wednesday, driven by declining U.S. Treasury yields, while poor supply bets fueled self-catalyzed metal palladium at a record high.

6. Aur: Gold rose 1 percent on Wednesday, driven by declining U.S. Treasury yields, while betting on supply shortfalls fueled metal palladium with automatic catalyst at a record high.

    7. REIT: The value of holdings of foreign portfolio investors (REITs) in domestic equities reached a record $ 555 billion in 2020-21, a huge increase of $ 105 billion between September 2020 and March 2021. Read more

7. FPI: The value of holdings of foreign portfolio investors (REITs) in domestic equities reached a record $ 555 billion in 2020-21, a huge increase of $ 105 billion between September 2020 and March 2021. Read more

    8. Finance: Listed firms eliminated 7.72 lakhore crore by issuing private placement bonds in 2020-21, an increase of 14% over the previous fiscal budget, supported by low interest rates and liquidity surpluses in system.  Read more

8. Finance: Listed firms eliminated 7.72 lakhs crore by issuing private placement bonds in 2020-21, a 14% increase over the previous fiscal budget, supported by low interest rates and liquidity surpluses in the system. Read more

    9. LIC: The Life Insurance Corporation of India (LIC) received new premiums of Rs 1.84 crore in fiscal year 21, which is the highest ever, even though most companies have been affected by the COVID blockade.  This is up 3.4 percent or about 1.7 lakh crore.  Read more

9. LIC: Life Insurance Corporation of India (LIC) received new premiums of 1.84 lakh crore in fiscal year 21, which is the highest ever, even though most companies have been affected by the COVID blockade. This is up 3.4 percent or about 1.77 lakh crore. Read more

    10. COVID-19: Bharat Biotech and the Indian Medical Research Council (ICMR) - the developers of the indigenous COVID-19 Covaxin vaccine - claimed that their vaccine demonstrated an intermediate overall clinical efficacy of 78% and 100% efficacy against severe COVID disease. 19.  Read more

10. COVID-19: Bharat Biotech and the Indian Medical Research Council (ICMR) – the developers of the indigenous COVID-19 Covaxin vaccine – have argued that their vaccine has demonstrated an intermediate overall clinical efficacy of 78% and 100% efficacy against severe COVID-19 disease. Read more

Posted: April 22, 2021 7:46 AM IST




advertisement

Source